Baixar PDF
Artigo anterior
Voltar à página
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice
Carla Boquimpani; Fernanda Salles Seguro; Gustavo Henrique Romani Magalhães; Ingrid Luise Soares Pinto; Israel Bendit; Jaisson André Pagnoncelli Bortolini; Katia Borgia Barbosa Pagnano; Renato Centrone; Vaneuza Funke;
Hematol Transfus Cell Ther. 2022;44:402-9
Clinical and laboratorial characterization of a cohort of patients with hereditary platelet disorders in Brazil
Letícia Dalla Vecchia Grassi; Erica Okazaki; Cynthia Rothschild; Paula Villaça; Fernanda Andrade Orsi; Bianca Stefanello;
Hematol Transfus Cell Ther. 2025;47:
Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies
Tomasz Sacha; Katarzyna Krawczyk;
Hematol Transfus Cell Ther. 2025;47: